Fibroids: Patient Considerations in Management a Roundtable Featuring Joseph S

Fibroids: Patient Considerations in Management a Roundtable Featuring Joseph S

MDEDGE.COM/OBGYN | VOL 31, NO 7 | JULY 2019 WHAT’S THE VERDICT? The mesh mess Vaginal vs buccal route for cervical ripening at term The ACA 10 years later ACOG’S LUCIA DIVENERE, MA A member of the Network Fibroids: Patient considerations in management A roundtable featuring Joseph S. Sanfi lippo, MD, MBA; Linda D. Bradley, MD; and Ted L. Anderson, MD, PhD Options for reducing the number of prenatal visits Polyps and cancer risk, more AUB updates What’s the Diagnosis? Two cases of genital pruritus Uterus-sparing interventions for PPH at cesarean p. 4 FoFollowllow us on FFacebookacebook aandnd Twitter C1 0719.indd 1 7/1/19 3:18 PM Enhancing patient outcomes, managing costs, and optimizing delivery of care. The value of care: PREGNANCY From preconception to delivery, LabCorp offers comprehensive testing options to support healthy moms and healthy babies. Even before she’s pregnant, our ReproSure® ovarian reserve testing informs your course of care; our non-invasive prenatal testing options: MaterniT® 21 Plus, MaterniT GENOME; and Inheritest® carrier screening gives you a single source solution throughout the entire pregnancy continuum. Value beyond testing. LabCorp’s full-service offerings, specialty test options, genetic counseling programs, cost estimator, and coast-to-coast patient service centers set our value apart and put your patients at the heart of our efforts to improve health and improve lives. For more information, please visit www.labcorp.com/value-care-pregnancy ©2019 Laboratory Corporation of America® Holdings All rights reserved. 19875-0119 #1 IN READERSHIP!* mdedge.com/obgyn Enhancing the quality of women’s health care and the professional development of ObGyns and all women’s health care clinicians EDITOR IN CHIEF Robert L. Barbieri, MD Chief, Department of Obstetrics and Gynecology Brigham and Women’s Hospital Kate Macy Ladd Professor of Obstetrics, Gynecology, and Reproductive Biology Harvard Medical School Boston, Massachusetts BOARD OF EDITORS Arnold P. Advincula, MD David G. Mutch, MD Vice Chair and Levine Family Professor of Women’s Health, Ira C. and Judith Gall Professor of Obstetrics and Gynecology, and Department of Obstetrics & Gynecology, Columbia University Vice Chair, Department of Obstetrics and Gynecology, Washington Medical Center; Chief of Gynecologic Specialty Surgery, University School of Medicine, St. Louis, Missouri Sloane Hospital for Women, New York-Presbyterian Hospital/ Columbia University, New York, New York Errol R. Norwitz, MD, PhD, MBA, Section Editor Chief Scientifi c Offi cer, Tufts Medical Center; Louis E. Phaneuf Linda D. Bradley, MD Professor and Chairman, Department of Obstetrics & Gynecology, Professor of Surgery and Vice Chairman, Obstetrics, Gynecology, Tufts University School of Medicine, Boston, Massachusetts and Women’s Health Institute, and Vice Chair for Diversity and Inclusion for the Women’s Health Institute; and Director, Center for Menstrual Disorders, Fibroids, & Hysteroscopic Services, Cleveland JoAnn V. Pinkerton, MD, NCMP Clinic, Cleveland, Ohio Professor, Department of Obstetrics and Gynecology, and Director, Midlife Health, University of Virginia Health System, Amy L. Garcia, MD Charlottesville, Virginia; Executive Director, Th e North American Menopause Society, Pepper Pike, Ohio Medical Director, Garcia Sloan Centers; Center for Women’s Surgery; and Clinical Assistant Professor, Department of Obstetrics and Gynecology, John T. Repke, MD University of New Mexico, Albuquerque, New Mexico Professor Emeritus, Obstetrics and Gynecology, Penn State University College of Medicine, Hershey, Pennsylvania Steven R. Goldstein, MD, NCMP, CCD Professor, Department of Obstetrics and Gynecology, Joseph S. Sanfi lippo, MD, MBA New York University School of Medicine; Director, Gynecologic Professor, Department of Obstetrics, Gynecology, and Ultrasound, and Co-Director, Bone Densitometry, Reproductive Sciences, University of Pittsburgh; New York University Medical Center, New York, New York Academic Division Director, Reproductive Endocrinology and Infertility, Magee-Womens Hospital, Cheryl B. Iglesia, MD Pittsburgh, Pennsylvania Director, Section of Female Pelvic Medicine and Reconstructive Surgery, MedStar Health; James A. Simon, MD, CCD, IF, NCMP Professor, Departments of ObGyn and Urology, Clinical Professor, Department of Obstetrics and Gynecology, Georgetown University School of Medicine, Washington, DC George Washington University; Medical Director, IntimMedicine™ Specialists, Washington, DC Andrew M. Kaunitz, MD, NCMP, Section Editor University of Florida Term Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville; Medical Director and Director of Menopause and Gynecologic Ultrasound Services, UF Women’s Health Specialists at Emerson, Jacksonville, Florida *Source: Kantar Media, Medical Surgical Study June 2019, Obstetrics/Gynecology Combined Office & Hospital Readers. mdedge.com/obgyn Vol. 31 No.7 | July 2019 | OBG Management 1 Masthead 0719.indd 1 7/1/19 3:16 PM JULY 2019 | VOL 31, NO 7 Follow us on Facebook and on Twitter @MDedgeObGyn 35 What’s the Verdict? The mesh mess, enmeshed in controversy JOSEPH S. SANFILIPPO, MD, MBA, AND STEVEN R. SMITH, JD 43 What’s Your Diagnosis? Two cases of genital pruritus: What is the one diagnosis? KERRIE G. SATCHER, MD; STEPHANIE J. CARSTENS, MD; AND ANDREW M. KAUNITZ, MD 47 Examining the Evidence Is the vaginal or buccal route more effective when administering prostaglandins for cervical ripening at term? ERROL R. NORWITZ, MD, PHD, MBA, 26 AND JULIE M. STONE, MD Roundtable Fibroids: Patient 4 Editorial Uterus-sparing interventions to treat considerations in medical postpartum hemorrhage during and surgical management cesarean delivery surgery DANIELA CARUSI, MD, MSC, Uterine fi broids can cause abnormal bleeding, pain, AND ROBERT L. BARBIERI, MD and infertility. ObGyns should be prepared to develop a treatment plan based on patient symptoms and goals. 8 Comment & Controversy A panel offers guidance based on experience and A classic approach for managing fetal malposition expertise. JOSEPH S. SANFILIPPO, MD, MBA; 50 OBG MARKETPLACE LINDA D. BRADLEY, MD; The offi cial job board of OBG MANAGEMENT AND TED L. ANDERSON, MD, PHD 52 Opioid prescriptions: 2019 snapshot 11 Update Abnormal uterine bleeding These experts discuss the factors that incur increased risk for malignant polyps, the relationship between chronic endometritis and endometrial polyps, whether the etonogestrel subdermal implant can treat EIN, and new endometrial ablation technology HOWARD T. SHARP, MD, AND MARISA R. ADELMAN, MD ACA 10 years later What’s your diagnosis? 15 The Affordable Care Act, 15 43 closing in on a decade LUCIA DIVENERE, MA FAST FAST TRACK is a system to enable you as a reader to move quickly through each issue of OBG MANAGEMENT, 21 Break This Practice Habit TRACK identifying articles or sections of articles to read in depth. Feasibility—and safety—of reducing OBG MANAGEMENT (ISSN 1044-307x) is published monthly by Frontline Medical Communications Inc, 7 Century Drive, Suite 302, Parsippany, New Jersey 07054. The contents of this publication may not be reproduced in whole the traditional 14 prenatal visits or part without the written consent of the owner. 2019 subscription rates (includes full-text access to mdedge.com /obgyn): United States: $162.00; elsewhere: $211.00. Single copy orders must be prepaid: United States: $27.00; to 8 or 10 Canada/Mexico: $33.00; other: $38.00. Periodicals postage paid at Parsippany, NJ, and additional mailing offi c- ERIN CLARK, MD; YVONNE BUTLER TOBAH, MD; es. Orders and Claims: OBG Management, Subscription Service, P.O. Box 3000, Denville, NJ 07834-3000, phone (833) 836-2705, or e-mail [email protected]. POSTMASTER: Please send address changes to OBG AND LAUREN D. DEMOSTHENES, MD MANAGEMENT Subscription Service, 10255 W. Higgins Road, Suite 280, Rosemont, IL 60018-9914. COVER IMAGE: KIMBERLY MARTENS 2 OBG Management | July 2019 | Vol. 31 No. 7 mdedge.com/obgyn TOC_0719.indd 2 7/1/19 3:20 PM EDITORIAL STAFF EDITOR Lila O’Connor SENIOR EDITOR Kathy Christie WEB EDITOR Christina Manago at mdedge.com/obgyn EDITOR EMERITUS Janelle Yates CONTRIBUTING EDITORS Ronald T. Burkman, MD Springfi eld, Massachusetts WEB EXCLUSIVE Katherine T. Chen, MD, MPH New York, New York Lucia DiVenere, MA Washington, DC Expert advice for immediate Neal M. Lonky, MD, MPH Anaheim, California postpartum LARC insertion Mark D. Pearlman, MD Ann Arbor, Michigan Steven R. Smith, MS, JD San Diego, California Q&A WITH LISA HOFLER, MD ART, WEB, PRODUCTION CREATIVE DIRECTOR Mary Ellen Niatas DIRECTOR, JOURNAL MANUFACTURING SERVICES Michael Wendt Visit us online for daily news PRODUCTION MANAGER Donna Pituras PUBLISHING STAFF GROUP PUBLISHER Dianne Reynolds ACCOUNT MANAGER, WEST Judy Harway DIGITAL ACCOUNT MANAGER Alison Paton ACCOUNT MANAGER, SPECIAL EVENTS Guy Pawlak SUBSCRIPTION INQUIRIES [email protected] Video Library A stepwise approach to 7 Century Drive, Suite 302 Parsippany, NJ 07054-4609 the diffi cult bladder fl ap www.mdedge.com to prevent urinary tract CORPORATE injury during laparoscopic SVP, FINANCE Steven Resnick VP, OPERATIONS Jim Chicca hysterectomy VP, SALES Mike Guire CHRISTINE FOLEY, MD, VP, SOCIETY PARTNERS Mark Branca AND NICOLE DONNELLAN, MD VP, EDITOR IN CHIEF Mary Jo Dales VP, EDITORIAL DIRECTOR, CLINICAL CONTENT Karen Clemments Brought to you by the CHIEF DIGITAL OFFICER Lee Schweizer Society of Gynecologic Surgeons VP, DIGITAL

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    60 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us